Navigation Links
Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope

LEWISTON, Maine and THOUSAND OAKS, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Amgen has signed on as the presenting sponsor of The Dempsey Challenge: A Journey for Hope, a cycling and 5K fundraising event scheduled for October 4 in Lewiston, Maine. The event supports The Patrick Dempsey Center for Cancer Hope & Healing at Central Maine Medical Center.

The sponsorship provides an opportunity to expand Amgen's Breakaway from Cancer((R)) initiative, which aims to increase awareness of the important resources available to cancer patients from prevention to education, and patient care to advocacy and financial support. The program will be prominently integrated into The Dempsey Challenge through a Breakaway from Cancer parade recognizing, honoring, and celebrating cancer survivors. A Breakaway from Cancer Survivor Award will be presented by television and film actor Patrick Dempsey to a recipient who best represents the program's passion for survivorship; individuals will be nominated through The Dempsey Challenge web site.

Additionally, a Breakaway from Cancer booth will be set up on site at The Dempsey Challenge's Health and Wellness Expo to share information about free programs and services available to people affected by cancer.

"Amgen welcomes the opportunity to support The Patrick Dempsey Center for Cancer Hope & Healing," said Stuart Arbuckle, vice president and general manager of Amgen's Oncology Business Unit. "We are pleased to once again partner with Patrick Dempsey, a respected advocate in the fight against cancer and a long-time supporter of Amgen's Breakaway from Cancer initiative, to help connect patients with the support they need in the fight against cancer."

Dempsey Challenge participants may choose one of four cycling tours (10, 25, 50 and 100-mile distances) or a 5K (3.1 mile) run/walk. The event will serve as the primary fundraiser for the Dempsey Center, which provides free education programs and wellness services to cancer patients, families and caregivers.

"My mom is a four-time ovarian cancer survivor and I know first hand how dealing with cancer can impact someone's life," said Patrick Dempsey. "I am pleased that Amgen has stepped up to sponsor the main fundraising event for the Dempsey Center, which provides free support, education and wellness services to cancer patients, survivors and caregivers, complementing Amgen's national Breakaway from Cancer efforts."

Dempsey is scheduled to take part in the 50-mile tour along with pro cyclists George Hincapie, a five-time Olympian, and David Zabriskie, who holds the record for fastest time trial in Tour de France history.

"We are thrilled to be partners with an organization that is equally committed to the cancer community," said Dempsey Challenge event manager Wendy Tardif. "Amgen's reputation for patient education and support parallels our own mission and provides us with the opportunity to heighten our visibility internationally. We feel confident we will be able to reach our fundraising goal."

Although The Dempsey Challenge offers fundraising incentive opportunities for participants, no fundraising minimum is required. For more information, including an event schedule, registration tools and maps of event courses, please visit

About The Patrick Dempsey Center for Cancer Hope & Healing at Central Maine Medical Center

Founded in March of 2008 by actor and Maine native, Patrick Dempsey, The Patrick Dempsey Center for Cancer Hope & Healing provides free support, education and wellness services to enhance the quality of life of individuals, families and communities touched by cancer. The Dempsey Center strives to embrace the whole person including body, mind and spirit in a respectful, inclusive and healing environment. All of the Dempsey Center's services are provided free of charge and tax-deductible contributions are welcome. For more information, please visit

About Breakaway from Cancer

Founded by Amgen in 2005 as a complementary component to the company's sponsorship of the Amgen Tour of California, Breakaway from Cancer strives to raise awareness of the important resources available to cancer patients from prevention to education, and patient care to advocacy and financial support. The initiative includes charitable partners the National Coalition for Cancer Survivorship, Patient Advocate Foundation, Prevent Cancer Foundation and The Wellness Community, and it also has joined forces with the Lance Armstrong Foundation and The Patrick Dempsey Center for Hope and Healing at Central Maine Medical Center. Learn more at

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit

    Mary Klem, (media)
    Office: 805-447-6979

    The Patrick Dempsey Center for Cancer Hope & Healing
    And The Dempsey Challenge
    Chuck Gill, (media)
    Office: 207-795-2711



Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amgen to Present at the Thomas Weisel Healthcare Conference
2. Amgen to Present at the Baird Healthcare Conference
3. Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs
4. Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
5. Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29
6. Amgen Announces Webcast of 2009 Second Quarter Financial Results
7. Amgen Scholars Discover Their Potential During Summer Science Research Program and National Symposium
8. Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)
9. Amgen Appoints Rebecca M. Henderson to the Companys Board of Directors
10. 34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence
11. AUDIO from Medialink and Amgen: Experts Agree Infection in Cancer Patients Impacts Treatment Success
Post Your Comments:
(Date:11/27/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class ... (Long Term Support) into its Q-Suite 5.10 product line. , Making the change ... version of Asterisk that will receive not only security fixes, but feature and ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... ... , ... Jobs in hospital medical laboratories and in the imaging field lead ... Aureus Medical Group . These fields, as well as travel nursing, ... healthcare jobs through the company’s website, , The leading healthcare staffing ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast ... found on mammography, according to a study published online in the journal Radiology. ... on mammography may necessitate a change in treatment. , Breast MRI is the ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology: